Talk About a Bad Reputation: Is It OK to Continue Trimethoprim–Sulfamethoxazole Prophylaxis in the Face of Hyper K
- 10 June 2025
- journal article
- Published by Wiley in Transplant Infectious Disease
- Vol. 27 (4) , e70062
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Does Switching From Trimethoprim/Sulfamethoxazole to Atovaquone Result in Less Hyperkalemia? A Single‐Center Retrospective Analysis in Heart Transplant PatientsTransplant Infectious Disease, 2025
- Alternative Pneumocystis Pneumonia Prophylaxis in Solid Organ TransplantsTransplant Infectious Disease, 2024
- Trimethoprim-sulfamethoxazole significantly reduces the risk of nocardiosis in solid organ transplant recipients: systematic review and individual patient data meta-analysisClinical Microbiology and Infection, 2023
- Alternative pneumocystis prophylaxis in solid organ transplant recipients at two large transplant centersTransplant Infectious Disease, 2020
- Pneumocystis jiroveci in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of PracticeClinical Transplantation, 2019
- Tissue and blood protozoa including toxoplasmosis, Chagas disease, leishmaniasis, Babesia, Acanthamoeba, Balamuthia, and Naegleria in solid organ transplant recipients— Guidelines from the American Society of Transplantation Infectious Diseases Community of PracticeClinical Transplantation, 2019
- Use of Alternative Agents for Prevention of Opportunistic Infections in Heart and Lung Transplant RecipientsClinical Infectious Diseases, 2018
- Nocardia Infections in Solid Organ TransplantationAmerican Journal of Transplantation, 2013
- Hyponatremia and/or Hyperkalemia in Patients Treated with the Standard Dose of Trimethoprim-sulfamethoxazoleInternal Medicine, 2003